MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES
- 3 Years 2006/2009
- 252.800€ Total Award
Our bodies are composed by zillions of cells, which must work in the most strictly coordinated way. To do so, our cells continuously exchange information, by releasing messages under the form of secretory proteins (hormones, cytokines, antibodies). These messages are selectively deciphered by specific receptors (special proteins mounted on the external surface of our cells), very much like a key opens a given door. This implies that both keys and locks be perfectly shaped. Opening the wrong door (or not opening one when necessary) can cause disease. It is nor surprising, therefore, that our cells spend a tremendous amount of energy in producing perfect proteins. They are very attentive in blocking the release of bad ones, which are recognized and destroyed, the building blocks being recycled. At the same time, cells care about efficiency: good proteins must be secreted abundantly and rapidly. Think about the need of producing many good antibodies when you are ill.
We are beginning to understand the molecular machines that cells evolved to cope with these problems. This knowledge is rapidly translating into the understanding of the causes of some genetic disorders, and will ultimately allow designing the best therapies.
Our work focuses on a general mechanism that our cells utilize to inspect, select and transport secretory proteins. One rare bleeding disorder is caused by defects in this protein machine. As other diseases are likely caused by similar problems, we need to dissect the mechanisms that couple efficiency and fidelity in the protein factory of our cells. Only by knowing all the key components, we will be able to fix the molecular machines and cure the diseases.
Scientific Publications
- 2007 EMBO JOURNAL
Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis
- 2007 FEBS LETTERS
Managing and exploiting stress in the antibody factory
- 2012 ANTIOXIDANTS & REDOX SIGNALING
Production of H2O2 in the Endoplasmic Reticulum Promotes In Vivo Disulfide Bond Formation
- 2010 ANTIOXIDANTS & REDOX SIGNALING
Redox Remodeling Allows and Controls B-Cell Activation and Differentiation
- 2007 CURRENT MEDICINAL CHEMISTRY
Diseases originating from altered protein quality control in the endoplasmic reticulum
- 2009 ANTIOXIDANTS & REDOX SIGNALING
Stress as an Intercellular Signal: The Emergence of Stress-Associated Molecular Patterns (SAMP)
- 2010 SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Physiology and pathology of proteostasis in the early secretory compartment
- 2009 Blood
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition
- 2008 BRITISH JOURNAL OF HAEMATOLOGY
Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib
- 2010 DIABETES OBESITY & METABOLISM
From antibodies to adiponectin: role of ERp44 in sizing and timing protein secretion
- 2011 TRAFFIC
Oxidative Protein Folding in the Secretory Pathway and Redox Signaling Across Compartments and Cells
- 2008 EUROPEAN JOURNAL OF IMMUNOLOGY
Dampening Ab responses using proteasome inhibitors following in vivo B cell activation
- 2010 EMBO JOURNAL
Crystal structures of human Ero1 alpha reveal the mechanisms of regulated and targeted oxidation of PDI
- 2012 ANTIOXIDANTS & REDOX SIGNALING
Ero1 alpha Regulates Ca2+ Fluxes at the Endoplasmic Reticulum-Mitochondria Interface (MAM)
- 2008 EMBO JOURNAL
Protein quality control in the early secretory pathway
- 2008 Journal of cellular physiology
SELIL and HRD1 are involved in the degradation of unassembled secretory Ig-mu chains
- 2008 EMBO REPORTS
Crystal structure of human ERp44 shows a dynamic functional modulation by its carboxy-terminal tail
- 2008 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Building and operating an antibody factory: Redox control during B to plasma cell terminal differentiation
- 2010 MOLECULAR IMMUNOLOGY
CHOP-independent apoptosis and pathway-selective induction of the UPR in developing plasma cells
- 2010 TRAFFIC
Pathogenesis of ER Storage Disorders: Modulating Russell Body Biogenesis by Altering Proximal and Distal Quality Control
- 2010 TRAFFIC
ERp44 and ERGIC-53 Synergize in Coupling Efficiency and Fidelity of IgM Polymerization and Secretion
- 2007 PRION
Interplays Between Covalent Modifications in the Endoplasmic Reticulum Increase Conformational Diversity in Nascent Prion Protein
- 2007 Haematologica-The Hematology Journal
Bortezomib in the treatment of AL amyloidosis: targeted therapy?